| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PRRC2C STARD9 ZBTB21 IQSEC1 NAV1 FAM83G KIAA1191 RAPGEF2 PC DDX41 ENKD1 AHNAK2 NUAK2 | 7.29e-07 | 861 | 96 | 13 | 36931259 |
| Pubmed | 1.99e-06 | 407 | 96 | 9 | 12693553 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 4.93e-06 | 341 | 96 | 8 | 32971831 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SFMBT1 PHF2 ORC1 ZBTB39 SUPT6H RRP9 YLPM1 RBM28 CMAS PC DDX41 SPEN NOP2 RPL6 | 1.26e-05 | 1294 | 96 | 14 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PHF2 PDS5B CCNT1 WWOX PRRC2C YLPM1 RBM28 PC SSX1 DDX41 SPEN NOP2 | 1.28e-05 | 954 | 96 | 12 | 36373674 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ORC1 SUPT6H RRP9 YLPM1 ABCD3 PWWP3A RBM28 CMAS PC DDX41 NOP2 RPL6 | 1.82e-05 | 989 | 96 | 12 | 36424410 |
| Pubmed | Leat-associated seizures the possible role of EAAT2, pyruvate carboxylase and glutamine synthetase. | 2.26e-05 | 3 | 96 | 2 | 38086219 | |
| Pubmed | Expression of metanephric nephron-patterning genes in differentiating mesonephric tubules. | 4.11e-05 | 69 | 96 | 4 | 21491542 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | PHF2 PDS5B LIPA SUPT6H VCAN YLPM1 ABCD3 IQSEC1 CMAS DDX41 SPEN RPL6 | 4.37e-05 | 1082 | 96 | 12 | 38697112 |
| Pubmed | 4.51e-05 | 4 | 96 | 2 | 22479346 | ||
| Pubmed | 4.75e-05 | 233 | 96 | 6 | 37704626 | ||
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 4.83e-05 | 608 | 96 | 9 | 36089195 | |
| Pubmed | PHF2 PDS5B CCNT1 ZBTB39 CEBPE PRRC2C ZBTB21 RBM28 MED13L DDX41 SPEN NOP2 | 5.26e-05 | 1103 | 96 | 12 | 34189442 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PCNX2 ORC1 GDPD5 NAV1 MICAL3 JADE1 MED13L PC SPEN PLEKHM1 AHNAK2 BAHCC1 | 5.35e-05 | 1105 | 96 | 12 | 35748872 |
| Pubmed | PHF2 CCNT1 SETDB2 LTN1 ZBTB21 IQSEC1 RAPGEF2 CMAS DDX41 ZC3H3 ENKD1 BAHCC1 | 5.88e-05 | 1116 | 96 | 12 | 31753913 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 6.61e-05 | 361 | 96 | 7 | 30344098 | |
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | 6.97e-05 | 364 | 96 | 7 | 24778252 | |
| Pubmed | Group 3 innate lymphocytes make a distinct contribution to type 17 immunity in bladder defence. | 7.50e-05 | 5 | 96 | 2 | 35845169 | |
| Pubmed | 8.33e-05 | 653 | 96 | 9 | 22586326 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 28912382 | ||
| Pubmed | 1.12e-04 | 6 | 96 | 2 | 25877867 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | PDS5B SUPT6H RRP9 YLPM1 ZBTB21 ABCD3 RBM28 DDX41 SPEN NOP2 RPL6 | 1.23e-04 | 1024 | 96 | 11 | 24711643 |
| Pubmed | DNA Damage Regulates Translation through β-TRCP Targeting of CReP. | 1.25e-04 | 35 | 96 | 3 | 26091241 | |
| Pubmed | PRRC2C VCAN ABCD3 PRICKLE2 IQSEC1 NAV1 MICAL3 RAPGEF2 CMAS PC SLC1A2 RPL6 NUAK2 | 1.55e-04 | 1431 | 96 | 13 | 37142655 | |
| Pubmed | SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. | 1.57e-04 | 7 | 96 | 2 | 23415230 | |
| Pubmed | 1.57e-04 | 7 | 96 | 2 | 34504008 | ||
| Pubmed | PDS5B GGNBP2 GHRL ABI3BP PRRC2C STARD9 CTAGE1 YLPM1 ZBTB21 SPEN RPL6 PLXNA2 BAHCC1 | 1.67e-04 | 1442 | 96 | 13 | 35575683 | |
| Pubmed | 1.95e-04 | 430 | 96 | 7 | 32581705 | ||
| Pubmed | 2.03e-04 | 104 | 96 | 4 | 9205841 | ||
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 33749946 | ||
| Pubmed | 2.09e-04 | 8 | 96 | 2 | 24367096 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.61e-04 | 934 | 96 | 10 | 33916271 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 2.77e-04 | 605 | 96 | 8 | 28977666 | |
| Pubmed | 3.26e-04 | 332 | 96 | 6 | 37433992 | ||
| Pubmed | A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells. | 3.34e-04 | 10 | 96 | 2 | 23334414 | |
| Pubmed | 3.34e-04 | 10 | 96 | 2 | 22300732 | ||
| Pubmed | 3.34e-04 | 10 | 96 | 2 | 12837688 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ORC1 PDS5B CCNT1 LTN1 ABCD3 IQSEC1 RBM28 CMAS DDX41 NOP2 RPL6 AHNAK2 | 3.51e-04 | 1353 | 96 | 12 | 29467282 |
| Pubmed | 3.71e-04 | 220 | 96 | 5 | 24550385 | ||
| Pubmed | 3.86e-04 | 222 | 96 | 5 | 37071664 | ||
| Pubmed | 3.93e-04 | 483 | 96 | 7 | 36912080 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 4.00e-04 | 807 | 96 | 9 | 22681889 | |
| Pubmed | 4.08e-04 | 11 | 96 | 2 | 33113356 | ||
| Pubmed | 4.70e-04 | 655 | 96 | 8 | 35819319 | ||
| Pubmed | ADAR1 mediated regulation of neural crest derived melanocytes and Schwann cell development. | 5.92e-04 | 59 | 96 | 3 | 31924792 | |
| Pubmed | 6.71e-04 | 14 | 96 | 2 | 15548585 | ||
| Pubmed | 6.71e-04 | 14 | 96 | 2 | 27270601 | ||
| Pubmed | 6.74e-04 | 251 | 96 | 5 | 28077445 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 7.25e-04 | 877 | 96 | 9 | 20211142 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 7.53e-04 | 147 | 96 | 4 | 28977470 | |
| Pubmed | Nucleosome-interacting proteins regulated by DNA and histone methylation. | 7.73e-04 | 15 | 96 | 2 | 21029866 | |
| Pubmed | Esrrb Complementation Rescues Development of Nanog-Null Germ Cells. | 7.73e-04 | 15 | 96 | 2 | 29320730 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PCNX2 PHF2 WWOX SUPT6H NAV1 CDYL2 MICAL3 GREB1 ZNF385A RAPGEF2 KCNIP2 PLEKHM1 | 8.17e-04 | 1489 | 96 | 12 | 28611215 |
| Pubmed | PHF2 ORC1 CCNT1 GGNBP2 SUPT6H RRP9 LTN1 ABCD3 CDYL2 ZNF385A CMAS SPEN | 8.56e-04 | 1497 | 96 | 12 | 31527615 | |
| Pubmed | 8.82e-04 | 16 | 96 | 2 | 7633422 | ||
| Pubmed | 8.82e-04 | 16 | 96 | 2 | 24390927 | ||
| Pubmed | Identification of the human testis protein phosphatase 1 interactome. | 8.97e-04 | 68 | 96 | 3 | 21382349 | |
| Pubmed | 9.66e-04 | 272 | 96 | 5 | 31010829 | ||
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | 9.66e-04 | 272 | 96 | 5 | 25315684 | |
| Pubmed | 1.02e-03 | 71 | 96 | 3 | 33541421 | ||
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | 1.03e-03 | 1318 | 96 | 11 | 30463901 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 1.08e-03 | 162 | 96 | 4 | 31363146 | |
| Pubmed | 1.08e-03 | 418 | 96 | 6 | 34709266 | ||
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 1.12e-03 | 18 | 96 | 2 | 25363768 | |
| Pubmed | 1.12e-03 | 18 | 96 | 2 | 22434868 | ||
| Pubmed | 1.21e-03 | 167 | 96 | 4 | 22159717 | ||
| Pubmed | Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. | 1.25e-03 | 19 | 96 | 2 | 22561518 | |
| Pubmed | Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. | 1.25e-03 | 19 | 96 | 2 | 15063736 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.38e-03 | 774 | 96 | 8 | 15302935 | |
| Pubmed | 1.39e-03 | 20 | 96 | 2 | 20413507 | ||
| Pubmed | 1.39e-03 | 963 | 96 | 9 | 28671696 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.41e-03 | 440 | 96 | 6 | 34244565 | |
| Pubmed | 1.41e-03 | 777 | 96 | 8 | 35844135 | ||
| Pubmed | 1.43e-03 | 603 | 96 | 7 | 11181995 | ||
| Pubmed | Genome-wide association study in Chinese identifies novel loci for blood pressure and hypertension. | 1.53e-03 | 21 | 96 | 2 | 25249183 | |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.66e-03 | 182 | 96 | 4 | 32239614 | |
| Pubmed | 1.68e-03 | 22 | 96 | 2 | 17400205 | ||
| Pubmed | 1.69e-03 | 183 | 96 | 4 | 36129980 | ||
| Pubmed | 1.80e-03 | 808 | 96 | 8 | 20412781 | ||
| Pubmed | 1.84e-03 | 23 | 96 | 2 | 19805515 | ||
| Pubmed | 1.84e-03 | 23 | 96 | 2 | 29567669 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | 1.91e-03 | 1425 | 96 | 11 | 30948266 | |
| Pubmed | IGFBP2 ZNF391 VCAN LTN1 FAM83G MICAL3 KIAA1191 RAPGEF2 PC ZNF714 | 1.94e-03 | 1215 | 96 | 10 | 15146197 | |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | 1.99e-03 | 639 | 96 | 7 | 23443559 | |
| Pubmed | 2.02e-03 | 641 | 96 | 7 | 36057605 | ||
| Pubmed | 2.10e-03 | 645 | 96 | 7 | 25281560 | ||
| Pubmed | 2.13e-03 | 195 | 96 | 4 | 19454010 | ||
| Pubmed | 2.17e-03 | 25 | 96 | 2 | 21786021 | ||
| Pubmed | 2.25e-03 | 330 | 96 | 5 | 32529326 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 2.32e-03 | 486 | 96 | 6 | 30940648 | |
| Pubmed | 2.35e-03 | 26 | 96 | 2 | 27861515 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | 2.48e-03 | 1257 | 96 | 10 | 36526897 | |
| Pubmed | 2.49e-03 | 493 | 96 | 6 | 15368895 | ||
| Pubmed | 2.53e-03 | 27 | 96 | 2 | 34709416 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.69e-03 | 208 | 96 | 4 | 33230847 | |
| Cytoband | 11q13.4-q13.5 | 4.33e-06 | 2 | 96 | 2 | 11q13.4-q13.5 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.80e-06 | 169 | 96 | 6 | 44d201361eb497222a4972a0e10bac1e05dcfd0a | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.11e-06 | 195 | 96 | 6 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.49e-06 | 198 | 96 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-06 | 132 | 96 | 5 | 4152529611eeacf0c547e2a134d5b98c45426b13 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-MyoFB-1|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.57e-05 | 145 | 96 | 5 | ac41c6c02b7d78162b86222983688f54d04ac47d | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.79e-05 | 149 | 96 | 5 | a85a051e0d82430160967e72fa04b55f43e84513 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.84e-05 | 150 | 96 | 5 | 7a381f5ae94eba5eb60dcbf83416b4eb18c279ea | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.52e-05 | 160 | 96 | 5 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_B2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.36e-05 | 170 | 96 | 5 | c1f7f1bb8865e954bb499963d82bb51923d5d8d6 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 176 | 96 | 5 | 533d544852038c0612aacf87f4b1c88ff7aace82 | |
| ToppCell | Club_cells-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 3.97e-05 | 176 | 96 | 5 | 88c4ed0ab4a4ede8cad21385d799b723b5786cd9 | |
| ToppCell | 10x5'-Lung-Myeloid_Dendritic-migDC|Lung / Manually curated celltypes from each tissue | 4.41e-05 | 180 | 96 | 5 | e9e8992deb0beeee5548910e4616e7c990763d99 | |
| ToppCell | COPD-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 4.53e-05 | 181 | 96 | 5 | 675603a401d92cf9fdcd44e211ec899fa86a0d49 | |
| ToppCell | LA-11._Adipocyte|World / Chamber and Cluster_Paper | 4.77e-05 | 183 | 96 | 5 | b177be283e1553fb1f69a346f1ba79ad00297fa2 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 183 | 96 | 5 | 919c9861073d12fd12aecd7469b1478b13838c43 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.03e-05 | 185 | 96 | 5 | 7e3d9f5050e71e91021245c11101e994ae41d22b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 5.16e-05 | 186 | 96 | 5 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Control-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 5.16e-05 | 186 | 96 | 5 | e9e58c5871b4966cd3586b611703e21af8df6360 | |
| ToppCell | Control-Myeloid-DC_Mature|Control / Disease state, Lineage and Cell class | 5.29e-05 | 187 | 96 | 5 | 049780ca2a3e6adcd89dc2cf3095b5ad068b244a | |
| ToppCell | Control-Myeloid-DC_Mature|World / Disease state, Lineage and Cell class | 5.29e-05 | 187 | 96 | 5 | 51bfc450e78284796b02317e91830357850b5437 | |
| ToppCell | COPD-Myeloid-DC_Mature|COPD / Disease state, Lineage and Cell class | 5.43e-05 | 188 | 96 | 5 | de93ccb53edb8599da9e312db0e3af604c21f673 | |
| ToppCell | (3)_DC_activated|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 5.56e-05 | 189 | 96 | 5 | e977838793fc0eb1499e81018e33e4ccb4a5f0c5 | |
| ToppCell | COPD-Myeloid-DC_Mature|Myeloid / Disease state, Lineage and Cell class | 5.99e-05 | 192 | 96 | 5 | baebd462f464e7d0e462d07a74bb5d685a9fc3b6 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 6.30e-05 | 194 | 96 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | tumor_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 6.45e-05 | 195 | 96 | 5 | 72a7c4beb880390b29f3c5d6dd9dbb082af50fe2 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.45e-05 | 195 | 96 | 5 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 6.77e-05 | 197 | 96 | 5 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 6.77e-05 | 197 | 96 | 5 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Control-Stromal-Fibroblast|Stromal / Disease state, Lineage and Cell class | 6.77e-05 | 197 | 96 | 5 | 64cc5f61c88e9560b0f8f6f3151255dffb5c3d66 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 7.10e-05 | 199 | 96 | 5 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.27e-05 | 200 | 96 | 5 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.47e-06 | 199 | 92 | 8 | 6308_DN | |
| Drug | Daff | 2.21e-06 | 7 | 92 | 3 | CID000085990 | |
| Drug | Alverine citrate salt [5560-59-8]; Down 200; 8.4uM; PC3; HT_HG-U133A | 1.35e-05 | 193 | 92 | 7 | 6345_DN | |
| Drug | Isopropamide iodide [71-81-8]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.54e-05 | 197 | 92 | 7 | 2720_DN | |
| Disease | Salivary Gland Neoplasms | 4.31e-04 | 47 | 92 | 3 | C0036095 | |
| Disease | Age-related macular degeneration | 1.42e-03 | 18 | 92 | 2 | cv:C0242383 | |
| Disease | Cannabis use initiation | 1.42e-03 | 18 | 92 | 2 | EFO_0007586 | |
| Disease | Endometrioma | 1.64e-03 | 161 | 92 | 4 | C0269102 | |
| Disease | Endometriosis | 1.64e-03 | 161 | 92 | 4 | C0014175 | |
| Disease | cortical thickness | PDS5B WWOX VCAN YLPM1 NAV1 MICAL3 CMAS ADAM12 PLXNA2 PLEKHM1 | 2.46e-03 | 1113 | 92 | 10 | EFO_0004840 |
| Disease | Dwarfism | 2.75e-03 | 25 | 92 | 2 | C0013336 | |
| Disease | coronary artery calcification | 2.88e-03 | 450 | 92 | 6 | EFO_0004723 | |
| Disease | cortical surface area measurement | TRIM2 CLCN2 WWOX PRRC2C VCAN NAV1 MED13L PC ADAM12 PLXNA2 PLEKHM1 | 3.09e-03 | 1345 | 92 | 11 | EFO_0010736 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKPNPLLSRHKKSRG | 291 | Q96PM9 | |
| GLPRGAHKLLRAKKA | 2206 | Q9P281 | |
| CKPRGQLSGHLLKPR | 56 | Q5TEZ4 | |
| PRHGPKRKPVKSLSL | 101 | Q6ZW13 | |
| LGPGASLKRKDPKDH | 86 | Q9H0I2 | |
| LHKVKVGKSPPVRGS | 21 | P13611 | |
| DNPPKGALKKLIHAA | 276 | Q96RT6 | |
| APSPAGPLHKGKKAV | 186 | Q15744 | |
| ARKRASPTGGIKKPH | 26 | P0DPK5 | |
| AHLGHLGKGLMRKPP | 766 | O43184 | |
| KTRVPHSKLDKGPTG | 631 | O60563 | |
| LPGAKNKVKGNPHTV | 601 | Q5H9R4 | |
| LGPGEEAPKKKHRRN | 16 | Q96IS3 | |
| LLGPSKGAPLAKRSK | 741 | Q9NW13 | |
| LPVLHHKSKKGPPRQ | 711 | Q9NTI5 | |
| GPLNKRSTHGNKKPR | 146 | Q68DA7 | |
| PQKKLNLSHKGIGEP | 26 | A6NCL2 | |
| HNSSGLLSPLRKKPL | 576 | O94822 | |
| PKSIHTLGFPGRVKK | 361 | Q9H306 | |
| ALPSLDQKKRGGHKA | 36 | Q9Y215 | |
| GLHLLKPLSIPKRLG | 1376 | Q7RTP6 | |
| SPKRSGKIPPKLHNH | 361 | Q71F56 | |
| GILSNSGPPKKRHKG | 301 | Q4ZG55 | |
| NLLGSPKIKKGLSPH | 446 | Q9H3C7 | |
| KLPGFKKIHVLGFRP | 276 | Q17R60 | |
| EKLIVGKKPIGSLHP | 726 | Q6DN90 | |
| AAAKAKHGKPNHLPG | 371 | Q6ZQW0 | |
| GLVDKGPLKKLPHLS | 246 | A6NKB5 | |
| KSGKLKKIRADGPPH | 451 | O75051 | |
| GKHHLGLEEPKKLRP | 206 | P18065 | |
| VQLSGRPHLPGKKKI | 46 | Q6PID8 | |
| EHGKDRGNTPKKPRL | 376 | Q9UBC0 | |
| HPPGPTKKALKQRFL | 26 | Q9NS61 | |
| GPEGRLEDKLHKPKA | 26 | Q9Y5X9 | |
| KKDLGPKPALIGHRG | 221 | Q8WTR4 | |
| EGKKQPPRAHNLKPR | 281 | Q96A73 | |
| AILRGLKKKGIHHPT | 191 | Q9UJV9 | |
| RNPLGKLIKKGFGLH | 261 | Q96RW7 | |
| AHCKKSLLGRPFLPK | 286 | Q7Z3G6 | |
| PACKRHLLGRKPGAQ | 96 | Q13415 | |
| GKAKRGCSPRVKPQH | 196 | P12034 | |
| SKKPPAKLQPRALAG | 41 | Q9UBU3 | |
| VKLAKQGGRPDLLKH | 71 | Q8NEG2 | |
| AIHPGNPKLKKQLGP | 141 | P43004 | |
| GEGRLGHKRKQPLPK | 266 | Q92949 | |
| SPKHLRPKGQLQKEP | 421 | Q8N6P7 | |
| INFHGKKLKLGPAIR | 101 | Q92904 | |
| HGPKRIICEGPKKKA | 36 | P51168 | |
| HRQKGTPLALKQLPK | 81 | P0C263 | |
| LGKSHGSLKLKRQPH | 581 | Q68DL7 | |
| KKPLGLKGPALAEHP | 371 | A6ND36 | |
| ELKKPISLGHPGSLK | 516 | Q8NEY1 | |
| HKKGLRKSENPRGPL | 176 | Q2TAK8 | |
| AGGKRKKSAHQKPLP | 71 | Q9Y4G2 | |
| FKGSHKSGKQLPPHL | 381 | O75151 | |
| KSGKQLPPHLVQGAK | 386 | O75151 | |
| KTPTVHGLGPKKERL | 1646 | A0AVI2 | |
| ARGGSKGIPLKNIKH | 51 | Q8NFW8 | |
| KGIPLKNIKHLAGVP | 56 | Q8NFW8 | |
| EHKPGPIGKERSLKN | 2111 | Q9Y520 | |
| TKKSSHLPLGSPLKR | 1056 | Q9P2P6 | |
| LKKPHKRDPLQNSPG | 591 | Q6IE81 | |
| AHRPGKSNLKLPKGI | 396 | Q9H093 | |
| QKPPQASGLLLHRKG | 486 | Q9H093 | |
| KPKDHHQPLGRAKGV | 741 | P46087 | |
| QHLRKGPPHQKGSKR | 306 | Q9NZ20 | |
| GKQLHPPGKANISEK | 136 | Q16384 | |
| RALGLHGKKSGKPPL | 31 | P28288 | |
| GASLKGHLPKVQRPS | 751 | Q8IVF2 | |
| GTSHKRKRINPPLAK | 101 | Q8N8U2 | |
| AARGETHKPLKPALK | 686 | P51788 | |
| THKPLKPALKRGPSV | 691 | P51788 | |
| GLGPRKGTHLLKILK | 991 | Q7KZ85 | |
| KRNGAPHLPKIGDIK | 481 | Q9Y4G8 | |
| KFGLKSHVSKPPLRP | 361 | Q9Y2C2 | |
| GFKPPREHLNSKTKG | 521 | Q96T68 | |
| RLPFKKLKVNEHGSP | 491 | Q9ULJ3 | |
| RAPLTKDSGKPLHIK | 931 | Q8IXZ2 | |
| PGQHGKTPSLLKIQK | 531 | Q96N38 | |
| KTHRQSILAKLPPKG | 456 | P51449 | |
| GRLKARKHLKPEQPA | 956 | Q96T58 | |
| VPRKLLSHGKKPFSQ | 121 | Q02878 | |
| LHVIPRAKKGAEGKP | 181 | O43818 | |
| LKHKLKTPRPGCQGQ | 26 | Q8IUC6 | |
| HPKTGKRKRVAGDLP | 46 | Q9NZC7 | |
| EHAPAGRPIHKGKSK | 351 | Q86V40 | |
| QQRTKVHLPGHKKGP | 306 | P49750 | |
| RGLHLQALKPTKPGL | 126 | Q9UK55 | |
| GFGLQHPALQKRKLP | 571 | O15060 | |
| LQGHPKIHIGEKPRK | 486 | Q9UJU3 | |
| KKKNKRIGRPPGGHS | 641 | Q9UHJ3 | |
| GKLPSRGPKHLKLTP | 126 | P0C1S8 | |
| RGPKHLKLTPAPLKD | 131 | P0C1S8 | |
| PGSGHVKQKAVKRPA | 441 | Q9C040 | |
| LALGNAQKLPKGKRP | 16 | Q7Z7G0 | |
| TPKHLVRGEGQKAKL | 26 | A0A087WV62 | |
| HPKALKDVKGQIGAP | 1101 | P11498 | |
| LLHSKPPKPTQARGK | 136 | Q13487 | |
| RSHGKKLPPASLKHR | 1046 | Q6PFW1 | |
| KIPKGHGSPISRKNS | 76 | Q9UJN7 | |
| IPHGRKNHSDKGPKP | 66 | P38571 |